Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 636.60M | $ 787.70M | $ 1.42B | $ 776.00M | $ 1.44B |
Total Assets | $ 4.37B | $ 3.83B | $ 4.86B | $ 8.29B | $ 8.68B |
Total Debt | $ 2.11B | $ 1.41B | $ 1.59B | $ 3.82B | $ 4.42B |
Net Debt | $ 1.48B | $ 626.10M | $ 170.50M | $ 3.04B | $ 2.98B |
Total Liabilities | $ 3.61B | $ 2.95B | $ 3.66B | $ 7.14B | $ 7.67B |
Stockholders Equity | $ 747.80M | $ 876.60M | $ 1.22B | $ 1.18B | $ 1.04B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |